ALK and non-small cell lung carcinoma: Regarding treatment, ALK inhibitors are effective for NSCLC with an ALK fusion gene because ALK tyrosine kinase is automatically activated by multimerization with fusion partner genes, causing the overexpression of cell proliferation signals [3].